李显龙总理再次确诊新冠,医生称其为“反弹”感染

新加坡总理李显龙在短暂康复后再次被检测出新冠病毒阳性。他在周四早晨的Facebook帖子中表示,他感觉良好,医生建议他自我隔离,直到抗原快速检测结果为阴性。

李总理说:“我的医生说这是新冠后反弹,这种情况在5到10%的病例中会发生。”他补充说,虽然仍有传染性,但与初次感染相比,风险并不高。

他原本非常期待参加今天早上的Sri Thendayuthapani Temple的献殿仪式,但为了确保他人安全,他不得不错过。“对组织者和所有参加仪式的人表示歉意,祝愿大家献殿和庆祝活动成功!”

李显龙,71岁,首次被检测出新冠阳性是在5月22日。医生建议他自我隔离,直到无症状,并由于他的年龄,开了抗病毒药物Paxlovid。

副总理黄永宏将在李显龙缺席期间担任代理总理,新加坡总理办公室周四发表声明。黄永宏将在周五主持第八次新加坡-澳大利亚年度领导人会议。

据路透社2022年的一份报道,美国政府研究人员的一项研究显示,服用Paxlovid的一些患者新冠症状反弹可能与健全的免疫系统有关,而不是弱的免疫系统。参与研究的患者症状反弹的都有较高的抗体水平,他们都不需要额外的治疗或住院。

PM Lee Tests Positive for Covid-19 Once More, Doctors Point to ‘Rebound’ Phenomenon Occurring in 5-10% of Cases

Singapore’s Prime Minister, Mr. Lee Hsien Loong, has again tested positive for Covid-19, a few days following his initial recovery from the virus. In a Facebook post on Thursday morning, he stated that he feels well and has been advised by his doctors to self-isolate until he tests negative on an antigen rapid test.

PM Lee explained that his doctors attribute his situation to a post-Covid rebound, a phenomenon that occurs in 5 to 10 percent of cases. He added that while he remains infectious, the risk is not as high compared to the initial infection.

PM Lee expressed his disappointment in having to miss the consecration ceremony of Sri Thendayuthapani Temple on Thursday morning, a decision made to ensure the safety of those around him. He expressed his regrets to the event organizers and attendees, wishing them a successful consecration and celebration.

Mr. Lee, 71, first tested positive for Covid-19 on May 22. His doctors advised him to self-isolate until he was symptom-free and prescribed the antiviral medication Paxlovid due to his age.

During PM Lee’s absence, Deputy Prime Minister Lawrence Wong will serve as Acting Prime Minister, as announced in a statement from the Prime Minister’s Office on Thursday. Mr. Wong will host the 8th Singapore-Australia Annual Leaders’ Meeting on Friday.

A 2022 Reuters report cited a study by US government researchers suggesting that a rebound of Covid-19 symptoms in some patients who took Paxlovid might be related to a robust immune system rather than a weak one. The patients in the study who experienced a rebound in symptoms had higher levels of antibodies, and none of them required additional treatment or hospitalization.